4.3 • 7.6K Ratings
🗓️ 20 May 2022
⏱️ 66 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | Support for this podcast comes from Regeneron. |
0:04.0 | Regeneron is a leading biotechnology company that |
0:07.0 | invents life-transforming medicines for people with serious diseases. |
0:11.0 | Their team of scientists and science supporters |
0:14.0 | seeks to accelerate and improve the traditional drug development process |
0:18.0 | through homegrown, bottleneck breaking technologies |
0:21.0 | and a one-of-a-kind genetic research group. |
0:24.0 | Now Regeneron is expanding their industry leading |
0:26.0 | antibody medicine capabilities and perfecting new approaches |
0:30.0 | like gene editing and engineering to spark the future |
0:33.0 | of genetics medicine. Discover how Regeneron is staying |
0:36.0 | on the cutting edge of science to build the medicines of tomorrow |
0:40.0 | at cspectacularscience.com. |
0:46.0 | The idea of a robot that vacuums and mobs your entire home is terrific. |
0:49.0 | The only problem is, well, it doesn't always work as promised. |
0:53.0 | Those little guys get whey-layed by walls, capsized by carpets |
0:56.0 | and flumics by furniture. Well, RoboRock has redesigned |
0:59.0 | the robotic vacuum, creating the convenient automated cleaning |
1:02.0 | you've been waiting for. RoboRock's award-winning automated |
1:05.0 | vacuum cleaners feature a navigation system that's precise, |
1:08.0 | consistent, and effective, even in the dark. |
1:11.0 | Plus, when you pay your vacuum with RoboRock's auto-empty dock, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Vox Media Podcast Network, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Vox Media Podcast Network and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.